newsfilter
← Latest News
GlobeNewswire·

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company ("BioAtla" or the "Company") focused on the development of Conditionally Active Biologic (CAB)